Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
After finishing at $26.27 in the prior trading day, Pfizer Inc. (NYSE: PFE) closed at $25.26, down -3.84%. In other words, the price has decreased by -$3.84 from its previous closing price. On the day, 47.42 million shares were traded. PFE stock price reached its highest trading level at $26.43 during the session, while it also had its lowest trading level at $25.25.
Ratios:
Our goal is to gain a better understanding of PFE by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 11.24 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 29.76. For the most recent quarter (mrq), Quick Ratio is recorded 0.69 and its Current Ratio is at 0.91. In the meantime, Its Debt-to-Equity ratio is 0.84 whereas as Long-Term Debt/Eq ratio is at 0.72.
On February 23, 2024, Guggenheim started tracking the stock assigning a Buy rating and target price of $36.
TD Cowen Downgraded its Outperform to Market Perform on January 04, 2024, while the target price for the stock was maintained at $32.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Dec 15 ’23 when Gottlieb Scott bought 3,000 shares for $26.47 per share. The transaction valued at 79,401 led to the insider holds 9,000 shares of the business.
Gottlieb Scott bought 1,000 shares of PFE for $38,580 on May 08 ’23. The Director now owns 6,000 shares after completing the transaction at $38.58 per share. On May 05 ’23, another insider, Gottlieb Scott, who serves as the Director of the company, bought 1,000 shares for $38.42 each. As a result, the insider paid 38,425 and bolstered with 5,000 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PFE now has a Market Capitalization of 148754874368 and an Enterprise Value of 205553614848. As of this moment, Pfizer’s Price-to-Earnings (P/E) ratio for their current fiscal year is 70.28, and their Forward P/E ratio for the next fiscal year is 9.24. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.44 while its Price-to-Book (P/B) ratio in mrq is 1.60. Its current Enterprise Value per Revenue stands at 3.514 whereas that against EBITDA is 17.848.
Stock Price History:
Over the past 52 weeks, PFE has reached a high of $40.37, while it has fallen to a 52-week low of $25.23. The 50-Day Moving Average of the stock is -6.54%, while the 200-Day Moving Average is calculated to be -17.45%.
Shares Statistics:
The stock has traded on average 42.31M shares per day over the past 3-months and 35759730 shares per day over the last 10 days, according to various share statistics. A total of 5.65B shares are outstanding, with a floating share count of 5.64B. Insiders hold about 0.04% of the company’s shares, while institutions hold 70.06% stake in the company. Shares short for PFE as of 1713139200 were 68062599 with a Short Ratio of 1.61, compared to 1710460800 on 71654031. Therefore, it implies a Short% of Shares Outstanding of 68062599 and a Short% of Float of 1.2.
Dividends & Splits
In the trailing 12 months, PFE’s forward annual dividend rate was 1.64, compared to 1.65 this year. Against a Trailing Annual Dividend Yield of 0.062428623The stock’s 5-year Average Dividend Yield is 3.97.
